MEDPACE HOLDINGS INC (MEDP) Stock Price, Quote, News and Overview
NASDAQ:MEDP - Nasdaq - US58506Q1094 - Common Stock - Currency: USD
MEDP Quote, Performance and Key Statistics
MEDPACE HOLDINGS INC
NASDAQ:MEDP (1/30/2025, 1:34:03 PM)
354.35
+11.33 (+3.3%)
The current stock price of MEDP is 354.35 USD. In the past month the price increased by 0.56%. In the past year, price increased by 16.03%.
MEDP Latest News, Press Releases and Analysis
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 10, 2025
MEDP Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 28.37 | 232.58B | ||
| DHR | DANAHER CORP | 29.71 | 160.72B | ||
| A | AGILENT TECHNOLOGIES INC | 28.68 | 43.27B | ||
| IQV | IQVIA HOLDINGS INC | 18.52 | 36.51B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 35.96 | 28.95B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 51.07 | 25.00B | ||
| WAT | WATERS CORP | 36.8 | 24.89B | ||
| ILMN | ILLUMINA INC | 77.5 | 21.26B | ||
| ICLR | ICON PLC | 14.42 | 16.71B | ||
| RVTY | REVVITY INC | 26.84 | 15.45B | ||
| AVTR | AVANTOR INC | 22.63 | 15.09B | ||
| TECH | BIO-TECHNE CORP | 40.96 | 11.65B |
Related stock screener links
About MEDP
Company Profile
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The company is headquartered in Cincinnati, Ohio and currently employs 5,900 full-time employees. The company went IPO on 2016-08-11. The firm is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The firm partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. Its drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The firm also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.
Company Info
MEDPACE HOLDINGS INC
5375 Medpace Way
Cincinnati OHIO 45227 US
CEO: August J. Troendle
Employees: 5800
Company Website: https://investor.medpace.com/
Investor Relations: https://investor.medpace.com/
Phone: 15135799911
MEDP FAQ
What is the stock price of MEDP?
The current stock price of MEDP is 354.35 USD.
What is the symbol for MEDPACE HOLDINGS INC stock?
The exchange symbol of MEDPACE HOLDINGS INC is MEDP and it is listed on the Nasdaq exchange.
On which exchange is MEDP stock listed?
MEDP stock is listed on the Nasdaq exchange.
Is MEDP a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for MEDP, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of MEDP.
Does MEDP stock pay dividends?
MEDP does not pay a dividend.
When does MEDP stock report earnings?
MEDP will report earnings on 2025-02-10, after the market close.
What is the Price/Earnings (PE) ratio of MEDP?
The PE ratio for MEDP is 31.03. This is based on the reported non-GAAP earnings per share of 11.42 and the current share price of 354.35 USD.
What is the Short Interest ratio of MEDP stock?
The outstanding short interest for MEDP is 4.53% of its float.
MEDP Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to MEDP. When comparing the yearly performance of all stocks, MEDP is one of the better performing stocks in the market, outperforming 71.1% of all stocks.
MEDP Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to MEDP. MEDP scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
MEDP Financial Highlights
Over the last trailing twelve months MEDP reported a non-GAAP Earnings per Share(EPS) of 11.42. The EPS increased by 33.72% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 17.65% | ||
| ROA | 17.54% | ||
| ROE | 41.47% | ||
| Debt/Equity | 0 |
MEDP Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 75% to MEDP. The Buy consensus is the average rating of analysts ratings from 16 analysts.
For the next year, analysts expect an EPS growth of 37.19% and a revenue growth 11.75% for MEDP